VYNE icon

VYNE Therapeutics

106 hedge funds and large institutions have $160M invested in VYNE Therapeutics in 2020 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 58 increasing their positions, 11 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
106
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$28.1M
2 +$11.7M
3 +$10.9M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$10.3M
5
BlackRock
BlackRock
New York
+$9.08M

Top Sellers

1 -$4.43M
2 -$3.92M
3 -$2.83M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$2.68M
5
O
OrbiMed
New York
-$2M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$148K
52
$119K
53
$113K
54
$106K
55
$106K
56
$104K
57
$100K
58
$96.4K
59
$95K
60
$92K
61
$87K
62
$86K
63
$79K
64
$78K
65
$71K
66
$70K
67
$66.5K
68
$66K
69
$64K
70
$62K
71
$56K
72
$47K
73
$45K
74
$44K
75
$43K